Case Number 3433
Request Date 13/01/2014
Completion Date 21/01/2014


Details of the Request

In your trust, how many patients with Multiple Sclerosis are currently being treated with the following drugs;

  • Interferon beta-1a [Avonex or Rebif]
  • Interferon beta-1b [Extavia or Betaferon]
  • Glatiramer acetate [Copaxone]
  • Natalizumab [Tysabri]
  • Fingolimod [Gilenya]
  • Alemtuzumab [Lemtrada]
  • Dimethyl fumarate [Tecfidera]
  • Teriflunomide [Aubagio]
  • Other


Details of the Response

Drug Name Brand Name Number of Patients
Interferon beta-1a Avonex 24
Interferon beta-1a Rebif 24
Interferon beta-1b Extavia 0
Interferon beta-1b Betaferon 3
Glatiramer acetate Copaxone 57
Natalizumab Tysabri 10 (but drug is not actually provided by ASPH)
Fingolimod Gilenya 24 (of which 13 are Sussex patients treated at ASPH due to consultant sick leave)
Alemtuzumab Lemtrada 0
Dimethyl fumarate Tecfidera 0
Teriflunomide Aubagio 0
Other   0
TOTAL   142